Role of heart rate in cardiovascular diseases: How the results of the BEAUTIFUL study change clinical practice

American Journal of Cardiovascular Drugs

Volumn 9, Issue SUPPL 1, 2009, Pages 9-12

  Cortada, Jordi Bruguera ^a   Varela, Alfonso ^b  

^a HOSPITAL DEL MAR   (Spain)

^b University Hospital of Santiago de Compostela   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IVABRADINE; PLACEBO; BENZAZEPINE DERIVATIVE;

ACUTE HEART INFARCTION; BLOOD PRESSURE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HEART RATE; HEART REHABILITATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; STABLE ANGINA PECTORIS; SYSTOLIC DYSFUNCTION; AGED; DRUG EFFECT; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

AGED; BENZAZEPINES; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77953009436     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.2165/1153162-S0-000000000-00000     Document Type: Conference Paper

References (23)

1. Fox K, Ferrari R, Tendera M, et al., BEAUTIFUL Steering Committee. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study. Am Heart J 2006; 152: 860-6.
2. Beautiful Study Group, Ferrari R, Ford I, Fox K, et al. The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction-baseline characteristics of the study population. Cardiology 2008; 110: 271-82.
3. Diaz A, Bourassa MG, Guertin MC, et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26: 967-74.
4. Jouven X, Empana JP, Schwartz PJ, et al. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005; 352: 1951-8. (Pubitemid 40638365)
5. Heidland U, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001; 104: 1477-82.
6. Fox M, Borer JS, Camm AJ, et al. RestingHeart rate in cardiovascular disease. J Am Coll Cardiol 2007; 50: 823-30.
7. Cucherat M. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J 2007; 28: 3012-19.
8. Fox K. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372: 807-16.
9. Fox K, Ford I, Steg PG, et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of randomised controlled trial. Lancet 2008; 372: 817-21.
10. Aboyans V, Criqui MH. Can we improve the cardiovascular risk prediction beyond risk equations in the physician's office? J Clin Epidemiol 2006; 59: 547-58.
11. Setakis E, Leufkens HGM, Williams TJ, et al. The effect of heart rate and its changes on cardiovascular disease and mortality. Eur Heart J 2007; 28 (Abstract suppl.): 778.
12. Theobald H, Wändell PE. Effect of heart rate on long-term mortality among mean and women. Acta Cardiol 2007; 62: 275-9.
13. Cacciatore F, Mazzella F, Abete P, et al. Mortality and heart rate in the elderly: role of cognitive impairment. Exp Aging Res 2007; 33: 127-44.
14. Macfarlane PW, Norrie J. The value of the electrocardiogram in risk assessment in primary prevention: experience from the West of Scotland Coronary Prevention Study. J Electrocardiol 2007; 40: 101-9.
15. Reil J-C, Danchin N, Thoenes M, et al. Relationship between heart rate and microalbuminuria in patients at high-risk for cardiovascular disease: results from the i-SEARCH study. Eur Heart J 2007; 28 (Abstract suppl.): 246.
16. Shalnova SA, Deev AD, Vikhireva OV. Resting heart rate as a coronary heart disease and total mortality predictor in Russian men with different CHD status. Eur Heart J 2007; 28 (Abstract suppl.): 778.
17. Moreau D, Potard D, Mock L, et al. Pre-discharge heart rate measured by 24H Holter monitoring and long term survival after acute myocardial infarction. Data from the RICO survey. Eur Heart J 2007; 28 (Abstract suppl.): 68.
18. Geha R, Gueret P, Meneveau N, et al. Prognostic impact of discharge heart rate after acute myocardial infarction according to use of beta-blockers: data from the French FAST-MI registry. Eur Heart J 2007; 28 (Abstract suppl.): 68.
19. Montalescot G, Dallongeville J, van Belle E, et al. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 2007; 28 (11): 1409-17.
20. Kjekshus JK. The effect of heart rate reduction on survival in heart Failure. Eur Heart J 2007; 28 (Abstract suppl.): 16.
21. ChoncholM, Goldenberg I, Moss AJ. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction. Am J Nephrol 2007; 27: 7-14.
22. Mehta RH, Califf RM, Yang Q, et al. Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock. Am J Cardiol 2007; 99: 793-6.
23. Stettler C, Bearth A, Allemann S, et al. QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23 year follow-up. Diabetologia 2007; 50: 186-94.